Review the list of the top discussion topics to gain insight from professionals from around the NHIA Community on the most pertinent and timely issues of the past year. Learn what other infusion providers are considering and jump in to share your perspective as well!
The NHIA Community provides you several ways to be notified of updates in the community, allowing you to adjust the frequency and format of your notifications. This way you know, on your schedule, when new discussion posts and replies are added or when there is other news or announcements.
The NHIA Community has officially been supporting and connecting our members for one year. Although this is still just the early days of this incredible resource for the home and alternate site infusion industry, we have seen some amazing things during year one and have a lot more planned to continue to improve the platform and what it offers NHIA members.
The National Home Infusion Association (NHIA) is pleased to announce that Michelle Simpson has recently earned the credential of Medical Writer Certified (MWC) after successfully completing the rigorous application and examination process developed and administered by the Medical Writing Certification Commission (MWCC) of the American Medical Writers Association (AMWA).
NHIA sent a letter to HHS requesting that the agency make permanent Medicare payment for COVID-19 monoclonal antibodies (mABs).
NHIF has adopted the Office of Management and Budget and Health and Human Services standard categories for race and ethnicity and urges all providers to include voluntary questions in their admissions process to capture this data.
On April 19, 2022, Baxter announced a supply disruption of the ExactaMix valve sets (ExactaMix 1200 Valve Set H938792 and ExactaMix 2400 Valve Set H938724) due to raw material constraints that are impacting production volumes. As a result, healthcare providers and institutions are driven to consider conservation measures when compounding using the ExactaMix Automated Compounder.
NHIA submitted comments on California SB 958, the Medication and Patient Safety Act of 2022, supporting amendments to the proposed legislation that allow for infused medications to be administered in the enrollee’s home when the physician and patient determine it is in the patient’s best interest and weighing in on various other aspects of the bill.
NHIA has compiled product shortage recommendations to help clinicians manage patient care and conserve prefilled NS syringe supplies during this time when they may not be readily available.
The National Home Infusion Foundation (NHIF) is proud to announce the publication of the first issue of Infusion Journal. The new scholarly journal features independent research and studies related to infused therapies, patient outcomes, medication safety, economic analyses, and case studies.
The National Home Infusion Foundation (NHIF) is proud to announce that Mitra Gavgani, PharmD has joined its Board of Directors for the 2022-2023 term.
NHIA submitted comments on a CMS proposed rule: Medicare and Medicaid Programs; CY 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs, which would alter the way pharmacy price concessions, including direct and indirect remuneration (DIR fees), are calculated by pharmacy benefit managers (PBMs).
The National Home Infusion Association (NHIA) is proud to announce that Erick Siegenthaler, PharmD, MHA, has joined the association’s Board of Directors for a 3-year term.
View photos from NHIA’s 2022 Annual Conference held in Nashville, Tennessee March 12-16.
More than 1,200 home infusion therapy professionals and 110 companies supplying products and services to the industry attended educational and networking events as well as a trade Expo.
The National Home Infusion Foundation (NHIF) is proud to announce that the recipient of the 2022 Outstanding Abstract Achievement Award (OAAA) is Cheyenne D. Johnson, PharmD from Option Care Health.
The National Home Infusion Foundation (NHIF) announces the finalists for its the Outstanding Abstract Achievement Award for 2022.
Review the list of the top discussion topics to gain insight from professionals from around the NHIA Community on the most pertinent and timely issues of the past year. Learn what other infusion providers are considering and jump in to share your perspective as well!
The NHIA Community provides you several ways to be notified of updates in the community, allowing you to adjust the frequency and format of your notifications. This way you know, on your schedule, when new discussion posts and replies are added or when there is other news or announcements.
The NHIA Community has officially been supporting and connecting our members for one year. Although this is still just the early days of this incredible resource for the home and alternate site infusion industry, we have seen some amazing things during year one and have a lot more planned to continue to improve the platform and what it offers NHIA members.
The National Home Infusion Association (NHIA) is pleased to announce that Michelle Simpson has recently earned the credential of Medical Writer Certified (MWC) after successfully completing the rigorous application and examination process developed and administered by the Medical Writing Certification Commission (MWCC) of the American Medical Writers Association (AMWA).
NHIA sent a letter to HHS requesting that the agency make permanent Medicare payment for COVID-19 monoclonal antibodies (mABs).
NHIF has adopted the Office of Management and Budget and Health and Human Services standard categories for race and ethnicity and urges all providers to include voluntary questions in their admissions process to capture this data.
On April 19, 2022, Baxter announced a supply disruption of the ExactaMix valve sets (ExactaMix 1200 Valve Set H938792 and ExactaMix 2400 Valve Set H938724) due to raw material constraints that are impacting production volumes. As a result, healthcare providers and institutions are driven to consider conservation measures when compounding using the ExactaMix Automated Compounder.
NHIA submitted comments on California SB 958, the Medication and Patient Safety Act of 2022, supporting amendments to the proposed legislation that allow for infused medications to be administered in the enrollee’s home when the physician and patient determine it is in the patient’s best interest and weighing in on various other aspects of the bill.
NHIA has compiled product shortage recommendations to help clinicians manage patient care and conserve prefilled NS syringe supplies during this time when they may not be readily available.
The National Home Infusion Foundation (NHIF) is proud to announce the publication of the first issue of Infusion Journal. The new scholarly journal features independent research and studies related to infused therapies, patient outcomes, medication safety, economic analyses, and case studies.
The National Home Infusion Foundation (NHIF) is proud to announce that Mitra Gavgani, PharmD has joined its Board of Directors for the 2022-2023 term.
NHIA submitted comments on a CMS proposed rule: Medicare and Medicaid Programs; CY 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs, which would alter the way pharmacy price concessions, including direct and indirect remuneration (DIR fees), are calculated by pharmacy benefit managers (PBMs).
The National Home Infusion Association (NHIA) is proud to announce that Erick Siegenthaler, PharmD, MHA, has joined the association’s Board of Directors for a 3-year term.
View photos from NHIA’s 2022 Annual Conference held in Nashville, Tennessee March 12-16.
More than 1,200 home infusion therapy professionals and 110 companies supplying products and services to the industry attended educational and networking events as well as a trade Expo.
The National Home Infusion Foundation (NHIF) is proud to announce that the recipient of the 2022 Outstanding Abstract Achievement Award (OAAA) is Cheyenne D. Johnson, PharmD from Option Care Health.
The National Home Infusion Foundation (NHIF) announces the finalists for its the Outstanding Abstract Achievement Award for 2022.
